Currently, bronchial asthma is considered as a chronic inflammatory process in the bronchi leading to hyperreactivity and bronchial obstruction. In this regard, the main direction in the treatment of bronchial asthma is anti-inflammatory (basic) therapy.
Hemosorption is considered as a method of detoxification (with the passage of blood through the hemosorbent the toxins are removed) and immunocorrection (the function of lymphocytes and phagocytes is activated, the number of receptors to cortisol on the surface of the lymphocyte membranes is increased).
For treatment of patients with bronchial asthma, the drugs of the prednisolone and triamcinolone group are most suitable.
The main criterion for prescribing antiasthmatic drugs in bronchial asthma is the degree of its severity.